Encapsulating peritoneal sclerosis in a peritoneal dialysis patient using Biocompatible fluids only: Is alport syndrome a risk factor?

Peritoneal Dialysis International

Volumn 30, Issue 2, 2010, Pages 240-249

  Sampimon, Denise E ^a   Vlijm, Anniek ^a   Phoa, Saffire S K S ^b   Krediet, Raymond T ^a   Struijk, Dirk G ^a,c  

^a Division of Nephrology   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Dianet Foundation   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; ALPORT SYNDROME; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; HYPERPARATHYROIDISM; INTESTINE OBSTRUCTION; MALE; PARATHYROIDECTOMY; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONITIS; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR;

ADULT; HEMODIALYSIS SOLUTIONS; HUMANS; MALE; NEPHRITIS, HEREDITARY; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; RISK FACTORS;

EID: 77957556767     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2009.00087     Document Type: Article

References (10)

1. Vlijm A, Stoker J, Bipat S, Spijkerboer AM, Phoa SSKS, Maes R, et al. Computed tomographic findings characteristic for encapsulating peritoneal sclerosis: a case-control study. Perit Dial Int 2009; 29:517-22.
2. Hendriks PM, Ho-dac-Pannekeet MM, van Gulik TM, Struijk DG, Phoa SS, Sie L, et al. Peritoneal sclerosis in chronic peritoneal dialysis patients: analysis of clinical presentation, risk factors, and peritoneal transport kinetics. Perit Dial Int 1997; 17:136-43.
3. Vardhan A, Zweers MM, Gokal R, Krediet RT. A solutions portfolio approach in peritoneal dialysis. Kidney Int Suppl 2003; 88:S114-23.
4. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 2003; 19:2543-56.
5. Mateijsen MA, van der Wal AC, Hendriks PM, Zweers MM, Mulder J, Struijk DG, et al. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 1999; 19:517-25.
6. Gregory M, Terreros DA, Barker DF, Fain PN, Denison JC, Atkin CL. Alport syndrome-clinical phenotypes, incidence, and pathology. Contrib Nephrol 1996; 117:1-28.
7. Fletcher S, Gibson J, Brownjohn AM. Peritoneal calcification secondary to severe hyperparathyroidism. Nephrol Dial Transplant 1995; 10:277-9.
8. Kawanishi H, Watanabe H, Moriishi M, Tsuchiya S. Successful surgical management of encapsulating peritoneal sclerosis. Perit Dial Int 2005; 25(Suppl 4):S39-47.
9. Giannakakis K, Massella L, Grassetti D, Dotta F, Perez M, Muda AO. Type VII collagen in Alport syndrome. Nephrol Dial Transplant 2007; 22:3501-7.
10. Naso M, Uitto J, Klement JF. Transcriptional control of the mouse Col7a1 gene in keratinocytes: basal and transforming growth factor-beta regulated expression. J Invest Dermatol 2003; 121:1469-78.